InflaRx N.V. (IFRX) vs Protalix BioTherapeutics, Inc. (PLX)

• InflaRx N.V. IFRX 1.31 ▼ −3.68%
• Protalix BioTherapeutics, Inc. PLX 2.54 ▲ +1.20%

InflaRx N.V. and Protalix BioTherapeutics, Inc. are both Biotechnology companies. InflaRx N.V. and Protalix BioTherapeutics, Inc. are of similar size ($204.7M and $192.3M). InflaRx N.V. has negative trailing earnings, so its P/E is not meaningful; Protalix BioTherapeutics, Inc. trades at 10.6×. Protalix BioTherapeutics, Inc. grew revenue faster over the last twelve months: 30.1% against −83.4%. Protalix BioTherapeutics, Inc. has the higher net margin (23.5% vs 0.00%) and the higher return on invested capital (48.5% vs −87.3%). Across the 16 metrics below, Protalix BioTherapeutics, Inc. leads on 12 and InflaRx N.V. on 4.